TO THE DIRECTOR OF — Cefixime Importer Profile
Pharmaceutical Importer · #12 buyer for Cefixime · $1.9M import value · 118 shipments · SUDAN · DGFT Verified
TO THE DIRECTOR OF is the #12 importer of Cefixime from India with $1.9M in import value and 118 verified shipments. TO THE DIRECTOR OF holds a 1.0% market share in Cefixime imports based in SUDAN. The company sources from 4 verified suppliers across 75 formulations shipped to 14 countries. Overall, TO THE DIRECTOR OF imports 3 pharmaceutical products worth $4.1M across 1 therapeutic categories.
TO THE DIRECTOR OF — Cefixime Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Cefixime to TO THE DIRECTOR OF?
Verified from 118 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI | $1.2M | 75 | 60.2% |
| SCOTT EDIL PHARMACIA LIMITED | $628.0K | 27 | 32.8% |
| B.M.PHARMACEUTICALS | $93.8K | 14 | 4.9% |
| SCOTT EDIL ADVANCE RESEARCH LABORATORIES EDUCATI | $39.3K | 2 | 2.1% |
TO THE DIRECTOR OF sources Cefixime from 4 verified Indian suppliers based on 118 customs records. The primary supplier is SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI accounting for 60.2% of imports.
How Does TO THE DIRECTOR OF Compare to Nearest Cefixime Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | PLANETPHARMA | FRANCE | $2.3M | 46 | $49.1K |
| 10 | MYLAN IRELAND LIMITED, | FRANCE | $1.8M | 54 | $33.7K |
| 12 | TO THE DIRECTOR OF ★ | SUDAN | $1.7M | 75 | $22.6K |
| 13 | LABOREX UGANDA LIMITED | KENYA | $1.7M | 66 | $25.2K |
| 5 | AL KAWKAB SCIENTIFIC BUREAU | JORDAN | $1.6M | 31 | $50.0K |
TO THE DIRECTOR OF ranks #12 among 1,805 Cefixime importers from India. Average shipment value of $22.6K compared to the market average of $13.3K. The closest competitors by value are PLANETPHARMA and MYLAN IRELAND LIMITED,.
Where Does TO THE DIRECTOR OF Import Cefixime To?
Destination countries from 118 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SUDAN | $956.1K | 51 | 50.0% |
| KENYA | $302.5K | 11 | 15.8% |
| PHILIPPINES | $136.2K | 20 | 7.1% |
| TANZANIA | $125.9K | 7 | 6.6% |
| AFGHANISTAN | $93.8K | 14 | 4.9% |
| CONGO D REPULIC | $83.7K | 3 | 4.4% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $50.0K | 1 | 2.6% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $50.0K | 1 | 2.6% |
| THAILAND | $43.2K | 1 | 2.3% |
| UGANDA | $30.8K | 3 | 1.6% |
TO THE DIRECTOR OF imports Cefixime to 14 countries. The primary destination is SUDAN receiving 50.0% of shipments worth $956.1K.
What Cefixime Formulations Does TO THE DIRECTOR OF Import?
| Formulation | Value | Shipments |
|---|---|---|
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME CAP 200 MG B.NO.4754Z001 TO 4754Z003 MFG.01/2024 EXP.12/NOS | $107.5K | 3 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME 400MG CAPSULESB.NO:0704Z017 MFG-12/24 EXP-11/27 | $100.0K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME CAPSULES USP 400MG B.NO: 0704Z018 & 0704Z019 MFG-12/24 E | $100.0K | 2 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME 400 MG CAPS. B.NO.0704Z004 MFG.01/2024 EXP.12/2026NOS | $69.0K | 6 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME DISPERSIBLE TABLETS 400MG 08725Z003 M 03 2025 E 02 2028 | $62.0K | 3 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME DISPERSIBLE 200MG TABLETS, | $50.0K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME 400MG CAPSULES B.NO:0704Z015 & 0704Z016 MFG-11/24 EXP-10 | $50.0K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME 400 MG CAPS. B.NO.0704Z005, 0704Z006 MFG.01/2024 EXP.12/ | $50.0K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME DISPERSIBLE 200MG TABS. | $50.0K | 1 |
| HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIXIME CAPSULES 400MG.(0704Z012 M.MAY-24 E.APR-27) | $50.0K | 1 |
TO THE DIRECTOR OF imports 75 distinct Cefixime formulations from India. The top formulation is HARMLESS PHARMACEUTICAL MEDICINES FINISHED FORMULATION CEFIX with 3 shipments worth $107.5K.
Who Are the Top Buyers of Cefixime from India and How Much Does TO THE DIRECTOR OF Import?
India exported $24.0M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. TO THE DIRECTOR OF imports $1.9M of this total, accounting for 1.0% of India's Cefixime exports with 118 shipments from SUDAN. This is verified from 118 customs shipment records covering 75 distinct formulations.
What Is the Average Order Value for TO THE DIRECTOR OF's Cefixime Imports?
TO THE DIRECTOR OF's average Cefixime order value is $16.2K per consignment, based on 118 shipments totaling $1.9M. TO THE DIRECTOR OF is based in SUDAN and ranks #12 among all Cefixime importers from India by value. The company sources from 4 verified suppliers in India.
Who Supplies Cefixime to TO THE DIRECTOR OF?
TO THE DIRECTOR OF sources Cefixime from 4 verified Indian suppliers: SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI ($1.2M, 60.2%), SCOTT EDIL PHARMACIA LIMITED ($628.0K, 32.8%), B.M.PHARMACEUTICALS ($93.8K, 4.9%), SCOTT EDIL ADVANCE RESEARCH LABORATORIES EDUCATI ($39.3K, 2.1%). This is based on 118 customs records.
How Does TO THE DIRECTOR OF Compare to Other Cefixime Importers?
TO THE DIRECTOR OF ranks #12 among 1,805 Cefixime importers from India with a 1.0% market share. The top 3 importers are AL-KAWKAB SCIENTIFIC BUREAU ($3.7M), PLANET PHARMA ($2.6M), SAAM GROUP LTD ($2.4M). TO THE DIRECTOR OF processed 118 shipments from SUDAN.
What Other Advanced Antibiotics Products Does TO THE DIRECTOR OF Import?
TO THE DIRECTOR OF also imports these advanced antibiotics products. Each links to the detailed product page.
About TO THE DIRECTOR OF
TO THE DIRECTOR OF imports 3 products worth $4.1M. Beyond Cefixime, top products include Ceftriaxone, Ceftazidime. View the complete TO THE DIRECTOR OF profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefixime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TO THE DIRECTOR OF matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TO THE DIRECTOR OF's capped import value divided by total capped export value for Cefixime across all Indian exporters.
- 5.Verified Records: This page is backed by 118 individual customs records matching TO THE DIRECTOR OF importing Cefixime, covering 75 formulations from 4 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefixime Import Data for TO THE DIRECTOR OF
Access order-level details, pricing data, supplier connections, and competitive analysis for TO THE DIRECTOR OF's Cefixime imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TO THE DIRECTOR OF
Full Company Profile →
3 products · $4.1M total trade · 1 categories
TO THE DIRECTOR OF × Cefixime
Verified from customs records
Company Overview
Top Products by TO THE DIRECTOR OF
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TO THE DIRECTOR OF.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current order-level data, contact TransData Nexus.